Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds

Mutation Research - Genetic Toxicology

Volumn 368, Issue 3-4, 1996, Pages 221-233

  Miller, Cecil ^a   Castonguay, Andre ^b   Teel, Robert W ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Metabolism; Mutagenicity; P 450 inducer; Phenol; Tobacco nitrosamine

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BETA NAPHTHOFLAVONE; CATECHIN; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; ELLAGIC ACID; ESCULETIN; ESCULIN; GALLIC ACID PROPYL ESTER; NITROSAMINE; PHENOBARBITAL; PHENOL DERIVATIVE; TOBACCO SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET; ENZYME INDUCTION; GENE EXPRESSION; HAMSTER; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SMOKING;

EID: 0001768235     PISSN: 01651218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(96)90064-6     Document Type: Article

References (57)

1. Adesnik M., Atchison M. Genes for cytochrome P-450 and their regulation. CRC Crit. Rev. Biochem. 19:1985;247-305.
2. Alaoui-Jamali M.A., Castonguay A., Schuller H.M. In vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone activated by hamster maternal and fetal tissues. Carcinogenesis. 9:1988;2319-2324.
3. Brunnemann K.D., Cox J.E., Hoffmann D. Analysis of tobacco-specific N-nitrosamines in indoor air. Carcinogenesis. 13:1992;2415-2418.
4. Burton H.R., Childs G.H., Anderson R.A., Fleming P.D. Changes in chemical composition of Burley tobacco during senescence and curing. 3. Tobacco-specific nitrosamines. J. Agric. Food. Chem. 37:1989;426-430.
5. Castonguay A., Lin D., Stoner G.D., Radok P., Furuya K., Hecht S.S., Schut H.A.G., Klaunig J.E. Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine , 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res. 43:1983;1223-1229.
6. Castonguay A., Allaire L., Charest M., Rossignol G., Boutet M. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultures with ellagic acid. Cancer Lett. 46:1989;93-105.
7. Charest M., Rossignol G., Castonguay A. In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues. Chem. -Biol. Interact. 71:1989;265-278.
8. Chen Z.K. The chemistry and biochemistry of tea. 1983;Chinese Tea Research Institute Press Inc. Hangzhau, China.
9. Crespi C.L., Penman B.W., Gelboin H.V., Gonzalez F.J. A tobacco smoke derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P-450s including polymorphic human cytochrome P-450 2D6. Carcinogenesis. 12:1991;1197-1201.
10. Devereux T.R., Anderson M.W., Belinsky S.A. Factors regulating activation and DNA alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells and the relationship to carcinogenicity. Cancer Res. 48:1988;4215-4221.
11. Domin B.A., Serabjit-Singh C.J., Philpot R.M. Quantitation of rabbit cytochrome P-450, form 2, in microsomal preparations bound directly to nitrocellulose paper using a modified peroxidase-immunostaining technique. Anal. Biochem. 136:1984;390-396.
12. Fischer S., Spiegelhalder B., Eisenbarth J., Preussmann R. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis. 11:1990;723-730.
13. Fischer S., Spiegelhalder B., Preussmann R. Tobacco-specific nitrosamines in European and USA cigarettes. Arch. Geschwulstforsch. 3:1990;169-177.
14. Fund D.Y., Liu L.L., Gailani M.B. Effect of phenolic antioxidants on microbial growth. CRC Crit. Rev. Microbiol. 12:1985;153-183.
15. Gochwendt M., Horn F., Kittstein W., Furstenberger G., Besemfelder E., Marks F. Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol: stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochem. Biophys. Res. Commun. 124:1984;63-68.
16. Guo Z., Smith T.J., Ishizaki H., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P-450 IIB1 in a reconstituted system. Carcinogenesis. 12:1991;2277-2282.
17. Guo Z., Smith T.J., Thomas P.E., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P-450 enzymes in rats. Arch. Biochem. Biophys. 298:1992;279-286.
18. Guttenplan J.B. Enhanced mutagenic activities of N-nitroso compounds in weakly acidic media. Carcinogenesis. 1:1980;439-444.
19. Haslam E. Conn E.V. The Biochemistry of Plants. Vol. 7:1981;527-533 Academic Press, New York, NY.
20. Haugen D.A., Peak M.J. Mixtures of polycyclic aromatic compounds inhibit mutagenesis in the Salmonella/microsome assay by inhibition of metabolic activation. Mutation Res. 116:1983;257-269.
21. Hecht S.S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1988;875-884.
22. Hecht S.S., Hoffmann D. The relevance of tobacco specific nitrosamines to human cancer. Cancer Surv. 8:1989;273-294.
23. Hecht S.S., Chen C.B., Ohmori T., Hoffman D. Comparative carcinogenicity in F344 rats of the tobacco specific nitrosmaines N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 40:1980;298-302.
24. Hecht S.S., Young R., Chen C.B. Metabolism in the F344 rat of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Cancer Res. 40:1980;4144-4150.
25. Hecht S.S., Lin D., Chen C.B. Comprehensive analysis of urinary metabolites of N′-nitrosonornicotine . Carcinogenesis. 2:1981;833-838.
26. Hecht S.S., Lin D., Castonguay A. Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis. 4:1983;305-310.
27. Hecht S.S., Spratt T.E., Trushin N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine . Carcinogenesis. 9:1988;161-165.
28. Hirayama T. Lung cancer in Japan: effects of nutrition and passive smoking. Mizell M., Correa P. Lung Cancer: Causes and Prevention. 1984;175-195 Verlag Chemie International Inc. Deerfield Beach, FL.
29. Hong J.-Y., Ding X., Smith T.J., Coon M.J., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P-450s NMa and NMb. Carcinogenesis. 13:1992;2141-2144.
30. Kuehnau J. The flavonoids. A class of semi-essential food components. Their role in human nutrition. World Rev. Nutr. Diet. 24:1976;117-191.
31. Linjinsky W., Andrews A.W. The superiority of hamster liver fraction for activating nitrosamines to mutagens in Salmonella typhimurium. Mutation Res. 111:1983;135-144.
32. Liu L., Castonguay A., Gerson S.L. Lack of correlation between DNA methylation and hepato-carcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 13:1992;2137-2140.
33. Lord H.L., Snieckus V.A., Josephy P.D. Re-evaluation of the effect of ellagic acid on dimethylnitrosamine mutagenicity. Mutagenesis. 4:1989;453-455.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 192:1951;265-275.
35. 1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis. 8:1987;1651-1656.
36. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Res. 113:1983;173-215.
37. Murphy S.E., Palomino A., Hecht S.S., Hoffmann D. Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 50:1990;5446-5452.
38. Nagabhushan M., Bhide S.V. Antimutagenicity of catechin against environmental mutagens. Mutagenesis. 3:1988;293-296.
39. Newmark H.L. A hypothesis for dietary components as blocking agents of chemical carcinogenesis: plant phenolics and pyrrole pigments. Nutr. Cancer. 6:1984;58-70.
40. Paolimi M., Sapigni E., Hrelia P., Scotti M., Morotti M., Cantelli-Forti G. Wide spectrum detection of precarcinogens in short-term bioassyas by simultaneous superinduction of multiple forms of cytochrome P-450 isoenzymes. Carcinogenesis. 12:1991;759-766.
41. Pepin P., Rossignol G., Castonguay A. Inhibition of NNK-induced lung tumorigenesis in A/J mice by ellagic acid and butylated hydroxyanisole. Cancer J. 3:1990;266-273.
42. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51:1991;5557-5564.
43. Peterson L.A., Mathew R., Hecht S.S. Quantitation of microsomal α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 12:1991;2069-2072.
44. Ryan R. Ph.D. Thesis. 1993;University of North Carolina.
45. Sagami I., Ohmachi T., Fujii H., Kikuchi H., Watanabe M. Hamster cytochrome P-450 IA gene family, P-450 IA1 and P-450 IA2 in lung and liver: cDNA cloning and sequence analysis. J. Biochem. 110:1991;641-647.
46. Serbjit-Singh C.-J., Wolf C.R., Philpot R.M. The rabbit pulmonary monooxygenase system: Immunochemical and biochemical characterization of enzyme components. J. Biol. Chem. 254:1979;9901-9907.
47. Smith T.J., Guo Z., Thomas P.E., Chung F.L., Morse M.A., Elkind K., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res. 50:1990;6817-6822.
48. Smith T.J., Guo Z., Hong J.Y., Ning S.M., Thomas P.E., Yang C.S. Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in microsomes of rat lung and nasal mucosa. Carcinogenesis. 13:1992;1409-1414.
49. Teel R.W. Effects of different inducers of cytochrome P-450 on mutagenesis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium TA1535. Anticancer Res. 12:1992;1287-1290.
50. Teel R.W., Castonguay A. Antimutagenic effects of polyphenolic compounds. Cancer Lett. 66:1992;107-113.
51. Tynes R.E., Philpot R.M. Tissue- and species-dependent expression of multiple forms of mammalian microsomal flavin-containing monooxygenase. J. Pharmacol. Exp. Ther. 31:1987;569-574.
52. Uwaifo A.D. The mutagenicities of seven coumarin derivatives and a furan derivative isolated from three medicinal plants. J. Toxicol. Environ. Health. 13:1984;521-530.
53. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
54. Wolf C.R., Moll E., Friedberg T., Oesch F., Buchmann A., Kuhlmann W W.E., Kunz H.W. Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P-450, compared with three further P-450 isoenzymes, NADPH P-450 reductase, glutathione transferase and microsomal epoxide hydrolase. Carcinogenesis. 5:1984;993-1001.
55. Wood A.W., Huang M.T., Chang R.L., Newmark H.L., Lehr R.E., Yagi H., Sayer J.M., Jerina D.M., Conney A.H. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occuring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. USA. 79:1982;5513-5517.
56. Yamazaki H., Inui Y., Yun C.H., Guengerich F.P., Shimada T. Cytochrome P-450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis. 13:1992;1789-1794.
57. Yang C.S., Brady J.F., Hong J.-Y. Dietary effects on cytochrome P-450, xenobiotic metabolism, and toxicity. FASEB J. 6:1992;737-744.